Gastrinoma
Showing 1 - 25 of 53
Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome
Completed
- Zollinger Ellison Syndrome
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 21, 2023
DOTATOC PET/CT for Imaging NET Patients
Recruiting
- Neuroendocrine Tumors
- +15 more
- 68Ga-DOTATOC PET/CT
- 18F-FDG PET/CT
-
Vancouver, British Columbia, CanadaBC Cancer
Nov 2, 2022
Neuroendocrine Tumors, Carcinoid Tumor, Pulmonary Carcinoid Tumor Trial in Vancouver (177Lu-DOTATOC)
Not yet recruiting
- Neuroendocrine Tumors
- +6 more
-
Vancouver, British Columbia, CanadaBC Cancer
Aug 19, 2022
Pancreatic Tumor, Benign, Pancreatic Tumors, Pancreatic Adenocarcinoma Trial in Houston (Distal Pancreatectomy Sealing Using
Completed
- Pancreatic Tumor, Benign
- +13 more
- Distal Pancreatectomy Sealing Using LTW
-
Houston, TexasBaylor CHI St. Luke's Medical Center
Apr 4, 2022
Gastrinoma, Glucagonoma, Insulinoma Trial in United States (regorafenib, laboratory biomarker analysis)
Completed
- Gastrinoma
- +8 more
- regorafenib
- laboratory biomarker analysis
-
Scottsdale, Arizona
- +4 more
Nov 15, 2021
Gastrinoma, Glucagonoma, Insulinoma Trial in Stanford (Capecitabine, Temozolomide, Bevacizumab)
Completed
- Gastrinoma
- +8 more
- Capecitabine
- +2 more
-
Stanford, CaliforniaStanford University Medical Center
Apr 8, 2021
Gastrinoma, Glucagonoma, Insulinoma Trial in Boston (everolimus, )
Gastrin-Producing Neuroendocrine Tumor, Lung Carcinoid Tumor, Metastatic Digestive System Neuroendocrine Tumor G1 Trial in
Completed
- Gastrin-Producing Neuroendocrine Tumor
- +10 more
- Laboratory Biomarker Analysis
- +2 more
-
Boston, Massachusetts
- +2 more
Mar 25, 2020
68Ga-HA-DOTATATE PET/CT in Adults With Neuroendocrine Tumors
Recruiting
- Neuroendocrine Tumors (NET)
- 68Ga-HA-DOTATATE PET/CT imaging
-
Calgary, Alberta, CanadaFoothills Medical Center 1403 29 St NW
Jan 4, 2023
Gastrinoma, Glucagonoma, Insulinoma Trial in United States (temozolomide, capecitabine, laboratory biomarker analysis)
Active, not recruiting
- Gastrinoma
- +6 more
-
Anaheim, California
- +322 more
Oct 14, 2022
Neuroendocrine Tumor Grade 2, Neuroendocrine Tumors Trial in Little Rock, Buffalo, Philadelphia (Capecitabine Oral Product,
Recruiting
- Neuroendocrine Tumor Grade 2
- Neuroendocrine Tumors
- Capecitabine Oral Product
- +2 more
-
Little Rock, Arkansas
- +2 more
Aug 11, 2022
Advanced Pancreatic Neuroendocrine Tumor, Locally Advanced Pancreatic Neuroendocrine Tumor, Pancreatic Gastrinoma Trial in
Completed
- Advanced Pancreatic Neuroendocrine Tumor
- +5 more
- Bevacizumab
- +2 more
-
Mobile, Alabama
- +393 more
Aug 3, 2022
Adult Hepatocellular Carcinoma, Advanced Adult Hepatocellular Carcinoma, Endometrial Serous Adenocarcinoma Trial in Canada,
Completed
- Adult Hepatocellular Carcinoma
- +44 more
- Bevacizumab
- Temsirolimus
-
Scottsdale, Arizona
- +60 more
Jan 24, 2019
Gastrinoma, Zollinger Ellison Syndrome Trial run by the NIDDK (Pantoprazole, Omeprazole)
Completed
- Gastrinoma
- Zollinger Ellison Syndrome
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
Gastrinoma, Glucagonoma, Insulinoma Trial (dovitinib lactate, pharmacological study, laboratory biomarker analysis)
Withdrawn
- Gastrinoma
- +5 more
- dovitinib lactate
- +2 more
- (no location specified)
Jul 18, 2017
Gastrointestinal Carcinoid Tumor, Islet Cell Tumor, Lung Cancer Trial in San Francisco, Vallejo (bevacizumab, 5-fluorouracil,
Terminated
- Gastrointestinal Carcinoid Tumor
- +4 more
- bevacizumab
- +3 more
-
San Francisco, California
- +1 more
Dec 12, 2019
Treatment of Zollinger-Ellison Syndrome
Completed
- Zollinger Ellison Syndrome
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
Islet Cell Adenoma, Zollinger Ellison Syndrome Trial run by the NIDDK (Interferon)
Completed
- Islet Cell Adenoma
- Zollinger Ellison Syndrome
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017
Functional Pancreatic Neuroendocrine Tumor, Malignant Somatostatinoma, Merkel Cell Carcinoma Trial (Capecitabine, Temozolomide,
Withdrawn
- Functional Pancreatic Neuroendocrine Tumor
- +28 more
- Capecitabine
- +4 more
- (no location specified)
Sep 26, 2017
Heavy Uterine Bleeding, Uterine Fibroids Trial (Elagolix , Elagolix, 0.5 mg estradiol / 0.1 mg norethindrone acetate)
Completed
- Heavy Uterine Bleeding
- Uterine Fibroids
- Elagolix placebo
- +4 more
- (no location specified)
Jul 7, 2020
Gastric Ulcer (GU), Duodenal Ulcer (DU), Anastomotic Ulcer (AU) Trial in Japan (D961H sachet 10 mg, D961H capsule 10mg, D961H
Completed
- Gastric Ulcer (GU)
- +5 more
- D961H sachet 10 mg
- +2 more
-
Bunkyo-ku, Japan
- +14 more
Nov 28, 2016
Paroxysmal Atrial Fibrillation Trial in Canada, United States (Atrial fibrillation ablation)
Completed
- Paroxysmal Atrial Fibrillation
- Atrial fibrillation ablation
-
Jacksonville, Florida
- +22 more
Sep 18, 2018
Hypercalcemia, Familial Primary Hyperparathyroidism Trial run by the NIDDK (Parathyroid hormone testing, Serum calcium testing)
Completed
- Hypercalcemia
- Familial Primary Hyperparathyroidism
- Parathyroid hormone testing
- Serum calcium testing
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017